Skip to main content
Noma survivors: closer to getting the attention they deserve

Neglected diseases

Neglected diseases disproportionally affect people in the world’s least-developed countries and there are few tools available with which to diagnose and treat.

They cover neglected tropical diseases, such as kala azar (visceral leishmaniasis) and sleeping sickness (human African trypanosomiasis), plus issues such as snakebite envenoming, but also Chagas, noma, cutaneous leishmaniasis, and others.

These diseases are considered ‘neglected’, as – although they are usually life-threatening and claim thousands of lives every year – the pharmaceutical and diagnostic industries ignore the development of vaccines, diagnostic tools and drugs to tackle them.

Neglected diseases

 
Chagas disease

Time to focus on patients

Project Update 7 Jul 2009
 
Chagas disease

Chagas disease not addressed by World Health Assembly - Neglected disease neglected once again

Press Release 19 May 2009
 
Sleeping sickness

NECT added to WHO Essential Medicines List as combination treatment against sleeping sickness

Press Release 15 May 2009
 
Neglected diseases

MSF and DNDi call for scale-up of R&D for neglected diseases

Press Release 23 Feb 2009
 
Kenya

If you can prick a finger, you can test for kala azar

Project Update 9 Feb 2009
 
India

More dead than alive - surviving kala azar

Project Update 24 Jul 2008
Advanced HIV management in Homa Bay
Medical Resource

MSF Field Research

We produce important research based on our field experience. So far, we have published articles in over 100 peer-reviewed journals. These articles have often changed clinical practice and have been used for humanitarian advocacy. All of these articles can be found on our dedicated Field Research website.

Visit site